335 related articles for article (PubMed ID: 12898360)
1. Pancreatic regeneration after ethionine-induced acute pancreatitis in rats lacking pancreatic CCK-A receptor gene expression.
Sato T; Niikawa J; Usui I; Imamura T; Yoshida H; Tanaka S; Mitamura K
J Gastroenterol; 2003; 38(7):672-80. PubMed ID: 12898360
[TBL] [Abstract][Full Text] [Related]
2. Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats).
Funakoshi A; Miyasaka K; Jimi A; Kawanai T; Takata Y; Kono A
Biochem Biophys Res Commun; 1994 Mar; 199(2):482-8. PubMed ID: 8135789
[TBL] [Abstract][Full Text] [Related]
3. Retardation of pancreatic regeneration after partial pancreatectomy in a strain of rats without CCK-A receptor gene expression.
Miyasaka K; Ohta M; Masuda M; Funakoshi A
Pancreas; 1997 May; 14(4):391-9. PubMed ID: 9163786
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin-1 receptor protein up-regulation during pancreatic regeneration after acute haemorrhagic pancreatitis in rats.
Yoshikawa H; Nakamura H; Tashiro M; Yamaguchi T; Taguchi M; Fukumitsu K; Otsuki M
Eur J Clin Invest; 2004 Jul; 34(7):498-507. PubMed ID: 15255787
[TBL] [Abstract][Full Text] [Related]
5. Role of cholecystokinin-A (CCK-A) receptor in pancreatic regeneration after pancreatic duct occlusion: a study in rats lacking CCK-A receptor gene expression.
Miyasaka K; Ohta M; Tateishi K; Jimi A; Funakoshi A
Pancreas; 1998 Mar; 16(2):114-23. PubMed ID: 9510132
[TBL] [Abstract][Full Text] [Related]
6. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
7. Effects of cholecystokinin (CCK)-8 on hypothalamic oxytocin-secreting neurons in rats lacking CCK-A receptor.
Hashimoto H; Onaka T; Kawasaki M; Chen L; Mera T; Soya A; Saito T; Fujihara H; Sei H; Morita Y; Ueta Y
Auton Neurosci; 2005 Aug; 121(1-2):16-25. PubMed ID: 15979947
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cholecystokinin in baseline and post-prandial whole body insulin sensitivity in rats.
Peitl B; Döbrönte R; Drimba L; Sári R; Varga A; Németh J; Pázmány T; Szilvássy Z
Eur J Pharmacol; 2010 Oct; 644(1-3):251-6. PubMed ID: 20624386
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous cholecystokinin in the regeneration of pancreatic tissue after acute hemorrhagic pancreatitis in rats.
Song W; Yamaguchi H; Nakano I; Kimura T; Nawata H
Fukuoka Igaku Zasshi; 1996 Jan; 87(1):14-22. PubMed ID: 8820983
[TBL] [Abstract][Full Text] [Related]
10. Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors.
Shilling PD; Feifel D
Synapse; 2002 Feb; 43(2):134-8. PubMed ID: 11754493
[TBL] [Abstract][Full Text] [Related]
11. Genetic verification of the role of CCK-AR in pancreatic proliferation and blood glucose and insulin regulation using a congenic rat carrying CCK-AR null allele.
Moralejo DH; Ogino T; Kose H; Yamada T; Matsumoto K
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):259-74. PubMed ID: 12889510
[TBL] [Abstract][Full Text] [Related]
12. Effects of the cholecystokinin receptor antagonist L-364,718 on pancreatitis induced by a deficient in choline and supplemented with ethionine (CDE) diet in the rat.
Manso MA; Rodriguez AI; Garcia-Montero AC; De Dios I
Arch Physiol Biochem; 1995 Aug; 103(4):410-5. PubMed ID: 8548474
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to the development of gastric mucosal damage in OLETF rat not expressing the CCK-A receptor.
Okumura T; Shoji E; Onodera S; Kohgo Y
Biochem Biophys Res Commun; 1996 Jul; 224(3):728-33. PubMed ID: 8713114
[TBL] [Abstract][Full Text] [Related]
14. Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects.
Moran TH; Bi S
Dev Psychobiol; 2006 Jul; 48(5):360-7. PubMed ID: 16770763
[TBL] [Abstract][Full Text] [Related]
15. Reduced CCK-induced Fos expression in the hindbrain, nodose ganglia, and enteric neurons of rats lacking CCK-1 receptors.
Covasa M; Ritter RC
Brain Res; 2005 Jul; 1051(1-2):155-63. PubMed ID: 16005445
[TBL] [Abstract][Full Text] [Related]
16. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.
Funakoshi A; Miyasaka K; Shinozaki H; Masuda M; Kawanami T; Takata Y; Kono A
Biochem Biophys Res Commun; 1995 May; 210(3):787-96. PubMed ID: 7539259
[TBL] [Abstract][Full Text] [Related]
17. Increased gastric acid secretion in cholecystokinin-1 receptor-deficient Otsuka Long-Evans Tokushima fatty rats.
Kanagawa K; Nakamura H; Murata I; Yosikawa I; Otsuki M
Scand J Gastroenterol; 2002 Jan; 37(1):9-16. PubMed ID: 11843043
[TBL] [Abstract][Full Text] [Related]
18. OLETF (Otsuka Long-Evans Tokushima Fatty) rats that lack the CCK 1 (A) receptor develop less behavioral sensitization to repeated cocaine treatment than wild type LETO (Long Evans Tokushima Otsuka) rats.
Beinfeld MC; Connolly K; Pierce RC
Peptides; 2001 Aug; 22(8):1285-90. PubMed ID: 11457522
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the metabolic effects of chronic clozapine treatment on CCK-1 receptor deficient Otsuka Long Evans Tokushima Fatty (OLETF) rats.
Hegedűs C; Kovács D; Drimba L; Sári R; Varga A; Németh J; Szilvássy Z; Peitl B
Eur J Pharmacol; 2013 Oct; 718(1-3):188-96. PubMed ID: 24036255
[TBL] [Abstract][Full Text] [Related]
20. Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Nakamura H; Kihara Y; Tashiro M; Kanagawa K; Shirohara H; Yamamoto M; Yoshikawa H; Fukumitsu K; Hirohata Y; Otsuki M
J Gastroenterol; 1998 Oct; 33(5):702-9. PubMed ID: 9773935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
